CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only
Phase 4 – monitoring after market approval
Conditions:
Contraception
Sponsor: Pohjois-Pohjanmaan hyvinvointialue, University Of Oulu
trial.available_in:
БГ
Overview
Trial status: Authorised
12-month use of study preparation, endpoint visit
Who can participate
Age group: 18-64 years
Gender: Female
Target enrollment: 156 participants
БГ